Oral Cancer Staging Workup
For an adult patient with suspected oral cancer, obtain pathological confirmation via biopsy, perform contrast-enhanced CT and/or MRI of the head and neck to assess the primary tumor and regional lymph nodes, and obtain chest CT (or preferably FDG-PET/CT) to evaluate for distant metastases and second primary tumors. 1
Mandatory Clinical Evaluation
Clinical assessment must include:
- Complete history focusing on chronic oral pain, non-healing ulcers, dysphagia, hoarseness, and neck masses 1
- Comprehensive physical examination with neck palpation 1
- Flexible head and neck fibreoptic endoscopy 1
- Performance status, nutritional status with weight assessment 1
- Dental examination (critical for treatment planning, especially if radiotherapy is anticipated) 1
- Speech and swallowing function assessment 1
Required laboratory tests:
- Complete blood count 1
- Liver enzymes, serum creatinine, albumin 1
- Coagulation parameters 1
- Thyroid-stimulating hormone (TSH) 1
Pathological Confirmation
Biopsy is mandatory before proceeding with staging workup. 1 For oral cavity lesions, examination and biopsy can typically be performed transorally under local anesthesia, while pharyngolaryngeal tumors often require endoscopic biopsy under general anesthesia. 1
Critical pathological features to document:
- Tumor size and growth pattern 1
- Depth of invasion (DOI) - specifically important for oral cavity cancer 1
- Perineural and lymphatic infiltration 1
Imaging Studies for Local and Regional Assessment
Contrast-enhanced CT and/or MRI of the head and neck are mandatory to assess the primary tumor and regional lymph nodes. 1 The two modalities are complementary and have similar diagnostic value for neck evaluation; discuss with a head and neck radiologist which is most appropriate. 1
For oral cavity cancers specifically:
Distant Metastasis Evaluation
Chest imaging is mandatory, particularly in high-risk patients (those with neck adenopathies or heavy smoking history). 1 At minimum, obtain chest CT. 1
FDG-PET combined with contrast-enhanced CT has higher sensitivity than either modality alone for detecting distant metastases and should be strongly considered, especially for apparent stage III/IV disease. 1 PET-CT may alter management by upstaging patients. 1
Endoscopic Evaluation
Rigid head and neck endoscopy under general anesthesia is strongly recommended for comprehensive mucosal evaluation. 1
Systematic bronchoscopy and esophagoscopy are NOT routinely advised but should be performed if driven by specific symptoms or diagnostic findings (e.g., hemoptysis, dysphagia). 1 The primary purpose is to identify synchronous second primary tumors in high-risk patients. 1
Special Pathological Considerations
For oral cavity cancer, p16 testing is NOT mandatory - the prognostic value of p16 has only been demonstrated in oropharyngeal squamous cell carcinoma, not in oral cavity tumors. 1 This distinguishes oral cavity from oropharyngeal cancer staging workup.
For recurrent or metastatic disease, PD-L1 expression should be evaluated to guide first-line treatment strategy. 1
Common Pitfalls to Avoid
- Do not delay biopsy for lesions persisting beyond 2 weeks after removal of local irritants 2
- Do not obtain CT or MRI before establishing pathological diagnosis - imaging should follow tissue confirmation 1
- Do not overlook dental evaluation - tooth extraction may be required before radiotherapy, and this should be coordinated early 1
- Do not forget to assess depth of invasion - this is a critical prognostic factor specific to oral cavity cancer that influences staging and treatment decisions 1
- Do not perform routine bronchoscopy/esophagoscopy unless symptoms warrant it - this represents unnecessary risk and cost 1
Staging Classification
Once workup is complete, classify according to the UICC TNM 8th edition, which incorporates depth of invasion as a key prognostic factor for oral cavity cancer. 1 The staging system is prognostic but should not independently dictate treatment strategy - treatment decisions require multidisciplinary tumor board discussion. 1